Business Of Biotech
By Matt Pillar
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Matt Pillar
Category: Management
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 28
Reviews: 0
Episodes: 252
Description
The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, and regulatory challenges you’ll face as you navigate your company from an idea to success in the clinic. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by Bioprocess Online and Life Science Connect and brought to you by Cytiva.
| Episode | Date |
|---|---|
|
Big Pharma Insights For Building Biotech Startups With Uniquity Bio's Brian Lortie
|
Apr 28, 2025 |
|
The Implications Of China's Growing Biotech Industry With Allan Shaw
|
Apr 21, 2025 |
|
How To Be A CFO With Insmed's Sara Bonstein
|
Apr 14, 2025 |
|
Deal And Investment Trends With Investment Banker David Sans
|
Apr 07, 2025 |
|
Business of Biotech 2.0 with Ben Comer
|
Mar 31, 2025 |
|
BoB@JPM: Nima Farzan, Latigo Biotherapeutics
|
Mar 24, 2025 |
|
BoB@JPM: Kasper Roet, Ph.D., QurAlis
|
Mar 17, 2025 |
|
BoB@JPM: Rick Modi, Affinia Therapeutics
|
Mar 10, 2025 |
|
BoB@JPM: Owen Hughes & Brad Sitko, XOMA Royalty
|
Mar 03, 2025 |
|
BoB@JPM: Tom Chalberg, Ph.D., Genascence
|
Feb 24, 2025 |
|
BoB@JPM: Ran Zheng, Landmark Bio
|
Feb 17, 2025 |
|
BoB@JPM: Peter Anastasiou, Capsida Biotherapeutics
|
Feb 10, 2025 |
|
BoB@JPM: Stefan Scherer, M.D., Ph.D., 3T Bioscience
|
Feb 03, 2025 |
|
The Business Of CNS with Acumen's Jim Doherty, Ph.D.
|
Jan 27, 2025 |
|
High-Throughput Discovery With Bioptic's Andrey Dobry
|
Jan 20, 2025 |
|
RNA Sandbox with Johns Hopkins RNA Innovation Center's Jeff Coller, Ph.D. and Michelle Kim, Ph.D.
|
Jan 13, 2025 |
|
Biotech Story Time With Tal Zaks, M.D. (Part 2, Tall Tales with Tal)
|
Jan 06, 2025 |
|
Risk Mitigation With Meira GTx's Zandy Forbes, Ph.D.
|
Dec 30, 2024 |
|
Biotech Story Time With Tal Zaks, M.D. (Part 1)
|
Dec 23, 2024 |
|
A $1B AI Bet With Foresite Labs' Vik Bajaj, Ph.D.
|
Dec 16, 2024 |
|
Manufacturing Partnership With Life Biosciences' Jerry McLaughlin and Forge Biologics' John Maslowski
|
Dec 09, 2024 |
|
Novel Peptide Delivery With Revolo's Woody Bryan, Ph.D.
|
Dec 02, 2024 |
|
Biopolitics With Allan Shaw
|
Nov 25, 2024 |
|
T-Cells For The Win With Adaptimmune's Adrian Rawcliffe
|
Nov 18, 2024 |
|
Serving The Underserved With Gates MRI's Claire Wagner, M.D.
|
Nov 11, 2024 |
|
An Unanticipated Biotech Startup With OS Therapies' Paul Romness
|
Nov 04, 2024 |
|
Building On Pandemic Progress With Barinthus Biotherapeutics' Bill Enright
|
Oct 28, 2024 |
|
Obesity Tx End-Around With Skye Bioscience's Punit Dhillon
|
Oct 21, 2024 |
|
Biotech C-Suite Construction With Allan Shaw
|
Oct 14, 2024 |
|
The Peptide Promise With NervGen's Mike Kelly
|
Oct 07, 2024 |
|
Biotech Course Correction With Treehill Partners' Ali Pashazadeh
|
Sep 30, 2024 |
|
An AI Awakening With Profluent Bio's Hilary Eaton, Ph.D.
|
Sep 23, 2024 |
|
Picking Biotech Jockeys With SR One's Simeon George, M.D.
|
Sep 16, 2024 |
|
Embracing Biotech Chaos With Memo's Erik van den Berg
|
Sep 09, 2024 |
|
Pivoting To RNA With Circio's Dr. Erik Digman Wiklund
|
Sep 02, 2024 |
|
mRNA Upstarts With Radar Therapeutics' Sophia Lugo and Eerik Kaseniit, Ph.D.
|
Aug 26, 2024 |
|
Steering Through Setbacks with AVEO Oncology's Michael Bailey
|
Aug 19, 2024 |
|
Leading From Within with ISCT & Kiji's Miguel Forte, M.D.
|
Aug 12, 2024 |
|
The Allogeneic Future with Poseida's Kristin Yarema, Ph.D.
|
Aug 05, 2024 |
|
Expanding The Proteome with ProFound's John Lepore, M.D.
|
Jul 29, 2024 |
|
From The Bench To The Boardroom with ImmunityBio's Enrique Diloné
|
Jul 22, 2024 |
|
First AI Antibody In Humans with Aulos' Aron Knickerbocker
|
Jul 15, 2024 |
|
Drug Delivery Differentiators with Syncromune's Eamonn Hobbs
|
Jul 08, 2024 |
|
Topical Ocular Biologics with Claris Bio's Clarke Atwell
|
Jul 01, 2024 |
|
C&G Regulatory Guidance with Lineage Therapeutics' Brian Culley
|
Jun 24, 2024 |
|
True DEI Value in Biopharma with Arcellx's Rami Elghandour
|
Jun 17, 2024 |
|
Mission-Driven Dementia Funding with DDF's Jonathan Behr
|
Jun 10, 2024 |
|
ADCs Ignited with Daiichi Sankyo Inc.'s Ken Keller
|
Jun 03, 2024 |
|
Accelerating ADCs with Mythic Therapeutics' Brian Fiske, Ph.D.
|
May 27, 2024 |
|
The Anti-CDMO with CTMC's Jason Bock, Ph.D. and KSQ's Thomas Leitch
|
May 20, 2024 |
|
A New Prescription For PBMs with Allan Shaw
|
May 13, 2024 |
|
New Apps For AI in mRNA With Anima Biotech's Yochi Slonim
|
May 06, 2024 |
|
Circular RNA with Orna Therapeutics' Tom Barnes, Ph.D. and Advancing RNA's Anna Rose Welch
|
Apr 29, 2024 |
|
Physician + Biotech Builder with Tome Biosciences' Rahul Kakkar, M.D.
|
Apr 22, 2024 |
|
Commercial Readiness with ImmunityBio's Bobby Reddy, M.D.
|
Apr 15, 2024 |
|
Precision Drug Delivery with Ampersand Biomedicines' Jason Gardner, D.Phil.
|
Apr 08, 2024 |
|
Funding Alzheimer's Tx Dev with ADDF's Karen Harris
|
Apr 01, 2024 |
|
The AI Impact with Generate:Biomedicines' Mike Nally
|
Mar 25, 2024 |
|
Strategic Deals with CinRx's Gavin Samuels, M.D.
|
Mar 18, 2024 |
|
Serial Success With Triumvira's Rob Williamson
|
Mar 11, 2024 |
|
The Innovator's Dilemma with Lumen Bioscience's Brian Finrow, J.D.
|
Mar 04, 2024 |
|
Precision Radiopharmaceuticals with Ratio's Jack Hoppin, Ph.D.
|
Feb 26, 2024 |
|
Managing Mergers With Sail Biomedicines' Guillaume Pfefer, Ph.D.
|
Feb 19, 2024 |
|
Reprogramming Human Cells With bit.bio's Mark Kotter, M.D.
|
Feb 12, 2024 |
|
Inhalable mRNA with Ethris' Carsten Rudolph, Ph.D.
|
Feb 05, 2024 |
|
Biotech Is Back with Allan Shaw
|
Jan 29, 2024 |
|
Multimodal R&D Management with Incyte's Jim Lee, M.D., Ph.D.
|
Jan 22, 2024 |
|
Building A Biotech Hub with Intellia Therapeutics' John Leonard, M.D.
|
Jan 15, 2024 |
|
Art Of The Pivot with Elevation Oncology's Joe Ferra
|
Jan 08, 2024 |
|
CDMO Collab with Scorpius BioManufacturing's Steve Lavezoli + Fina Biosolutions' Dr. Andrew Lees
|
Jan 01, 2024 |
|
Biotech Down Under with BiomeBank's Dr. Sam Costello
|
Dec 25, 2023 |
|
IL-2 Program Profits with Bonum's Drs. John Mulligan and Neela Patel
|
Dec 18, 2023 |
|
Public Sector Forged, Private Sector Tested with Renovaro BioSciences' Mark Dybul, M.D.
|
Dec 11, 2023 |
|
mRNA Vaccine Platforms with Combined Therapeutics' Dr. Romain Micol
|
Dec 04, 2023 |
|
Biotech Dealmaking with Regeneron's Nouhad Husseini
|
Nov 27, 2023 |
|
Backpacks And Biotech with Luke Timmerman
|
Nov 20, 2023 |
|
RNA Delivery Business with Liberate's Shawn Davis, Ph.D. & Walter Strapps, Ph.D.
|
Nov 13, 2023 |
|
The Legendary Steve Gorlin's Golden Rules
|
Nov 06, 2023 |
|
UPCOMING SPECIAL: Unraveling Biotech's Legal Enigmas With Keir LoIacono
|
Nov 01, 2023 |
|
CDMO + Emerging Bio Partnership with Forge's John Maslowski and Ray's Jenny Holt
|
Oct 30, 2023 |
|
Clinical Leadership with Cue Biopharma's Anish Suri, Ph.D. & Dan Passeri, J.D.
|
Oct 23, 2023 |
|
Bio Career Moves with Codagenix's Johanna Kaufmann, Ph.D.
|
Oct 16, 2023 |
|
Veteran Advice From The C-Suite with Citius' Leonard Mazur
|
Oct 09, 2023 |
|
Don't Be A D**k with Ochre Bio's Quin Wills, M.D., Ph.D.
|
Oct 02, 2023 |
|
Pragmatic Computational Biology with Andrew Satz
|
Sep 25, 2023 |
|
Commercial Readiness with Orca Bio's Dan Kirby
|
Sep 18, 2023 |
|
Bio & The Business Of Aging with Life Biosciences' Jerry McLaughlin
|
Sep 11, 2023 |
|
Fiscal Turnarounds with Protalix's Eyal Rubin
|
Sep 04, 2023 |
|
Building LEO Pharma's U.S. Presence with Brian Hilberdink
|
Aug 28, 2023 |
|
Managing Momentum With Rezolute Bio's Nevan Charles Elam, JD
|
Aug 21, 2023 |
|
Facing NASH Therapeutic Skepticism with 89bio's Rohan Palekar
|
Aug 14, 2023 |
|
Biotech Cash Management with Allan Shaw
|
Aug 07, 2023 |
|
Establishing Research With Horizon Therapeutics' Robert Stoffel, Ph.D.
|
Jul 31, 2023 |
|
Surviving The Microbiome Market with MaaT Pharma's Hervé Affagard
|
Jul 24, 2023 |
|
COO Liftoff With Rocket Pharmaceuticals' Kinnari Patel, PharmD
|
Jul 17, 2023 |
|
ML-Enabled Drug Discovery With LabGenius' James Field, Ph.D.
|
Jul 10, 2023 |
|
Biopharma Comebacks With Vincerx's Ahmed Hamdy, MD
|
Jul 03, 2023 |
|
Origins Of A Biopharma VC Deal With Bernat Olle, Ph.D. and Parag Shah
|
Jun 26, 2023 |
|
Population-Level Health Impact With Vaxxinity's John Krayacich
|
Jun 19, 2023 |
|
The Face Of African Biotech with Adrienne Leussa, Ph.D.
|
Jun 12, 2023 |
|
The Innovation Reduction Act with Allan Shaw
|
Jun 05, 2023 |
|
Propagating Peptides With Peptilogics' Jonathan Steckbeck, Ph.D.
|
May 29, 2023 |
|
Resilient Biopharma Leadership With Ambrx's Dan O'Connor
|
May 22, 2023 |
|
Funding A Neurodegeneration Startup With Coya Therapeutics' Howard Berman
|
May 15, 2023 |
|
A More NIIMBL Biotech Workforce With John Balchunas
|
May 08, 2023 |
|
Building Flagship Pioneering With Avak Kahvejian, Ph.D.
|
May 01, 2023 |
|
Therapeutic Molecules From Moss with eleva's Andreas Schaaf and Björn Cochlovius, Ph.D.
|
Apr 24, 2023 |
|
Gene Tx For Hearing Loss with Sensorion's Nawal Ouzren
|
Apr 17, 2023 |
|
Functional Ectopic Organs with LyGenesis' Michael Hufford, Ph.D.
|
Apr 10, 2023 |
|
Approvals & Mergers: Inside Enzyvant with Bill Symonds, Pharm.D.
|
Apr 03, 2023 |
|
Next-Gen Nanobodies With MoonLake's Jorge Santos Da Silva, Ph.D.
|
Mar 27, 2023 |
|
Lessons From The Bone Therapeutics/Medsenic Merger With BioSenic's François Rieger, Ph.D.
|
Mar 20, 2023 |
|
TCRs In Personalized Oncology With BlueSphere Bio's Keir Loiacono
|
Mar 13, 2023 |
|
BoB@JPM: Self-Replicating RNA With Elixirgen's Akihiro Ko
|
Mar 06, 2023 |
|
BoB@JPM: Gene Writing With Tessera's Michael Severino, M.D.
|
Feb 27, 2023 |
|
BoB@JPM: Post-IPO With Bolt Biotherapeutics' Drs. Randall Schatzman and Edith Perez
|
Feb 20, 2023 |
|
BoB@JPM: Academia To Industry With Oncolytics' Matt Coffey, Ph.D.
|
Feb 13, 2023 |
|
BoB@JPM: Support Of A Blossoming Pipeline With Sangamo's Sandy Macrae, Ph.D.
|
Feb 06, 2023 |
|
Building A Better COVID Vaccine With Ocugen's Shankar Musunuri, Ph.D.
|
Jan 30, 2023 |
|
Modality-Agnostic Drug Discovery With Cullinan Oncology's Nadim Ahmed
|
Jan 23, 2023 |
|
Women In Biotech With Bill & Melinda Gates MRI's Piper Trelstad, Ph.D.
|
Jan 16, 2023 |
|
Computational Drug Discovery With Gain Therapeutics' Matthias Alder
|
Jan 09, 2023 |
|
Dissecting Spesolimab's Approval With Boehringer Ingelheim's Carine Boustany
|
Jan 02, 2023 |
|
AI & Computational Biology With Recursion's Chris Gibson, Ph.D.
|
Dec 26, 2022 |
|
Allan Shaw On Financing Biopharma Innovation
|
Dec 19, 2022 |
|
Gene Therapy For Chronic Inflammation With Xalud's Howard Rutman, M.D.
|
Dec 12, 2022 |
|
The Antibody Engine With Abpro's Chan Brothers
|
Dec 05, 2022 |
|
In-Vivo CAR T Update With Umoja Biopharma's David Fontana, Ph.D.
|
Nov 28, 2022 |
|
RNA-Based Therapeutics With Nutcracker Therapeutics' Dr. Geoff Nosrati
|
Nov 21, 2022 |
|
Tick-Derived Therapeutic Molecules With Akari Therapeutics' Rachelle Jacques
|
Nov 14, 2022 |
|
Product vs. Platform With Surface's Vito Palombella, Ph.D. and Robert Ross, M.D.
|
Nov 07, 2022 |
|
Leveraging Lymph Nodes With Elicio's Dr. Peter DeMuth
|
Oct 31, 2022 |
|
Engineering Proteins For Food Allergies With Ukko's Dr. Anat Binur
|
Oct 24, 2022 |
|
Anatomy Of A VC Deal With 4BIO's Dima Kuzmin & Ray Therapeutics' Paul Bresge
|
Oct 17, 2022 |
|
Oncology Discovery Advances With AbbVie's Steve Davidsen, Ph.D.
|
Oct 10, 2022 |
|
IND For TIL Therapy With Obsidian Therapeutics' Paul Wotton, Ph.D.
|
Oct 03, 2022 |
|
Regenerative Wound Care With BioStem Technologies' Jason Matuszewski & Andrew VanVurst
|
Sep 26, 2022 |
|
Epigenomic Programming With Omega Therapeutics' Mahesh Karande
|
Sep 19, 2022 |
|
IDO Target Perseverence With IO Biotech's Mai-Britt Zocca, Ph.D.
|
Sep 12, 2022 |
|
Pursuit Of A Universal Flu Vaccine With Longhorn Vaccines & Diagnostics' Jeff Fischer
|
Sep 05, 2022 |
|
Genetic Testing & Neurodegenerative Disorders With AviadoBio's Lisa Deschamps
|
Aug 29, 2022 |
|
Biotech M&A Anomalies With Allan Shaw
|
Aug 22, 2022 |
|
Observations On Outsourcing With Molecule to Market's Raman Sehgal
|
Aug 15, 2022 |
|
What's A Biologic Revolution? With Vaxxinity's Mei Mei Hu, J.D.
|
Aug 08, 2022 |
|
Creative Capital Generation With James Thomas Coates, Ph.D.
|
Aug 01, 2022 |
|
Oligonucleotide Opportunities in DMD with PepGen's James McArthur, Ph.D.
|
Jul 25, 2022 |
|
Changing The Diabetes Care Paradigm With Arecor's Dr. Sarah Howell
|
Jul 18, 2022 |
|
Innate Immunity & Mouse Models With LIfT Biosciences' Alex Blyth
|
Jul 11, 2022 |
|
Antibody Cocktails With Immunome's Dr. Purnanand Sarma
|
Jul 04, 2022 |
|
Antibody-Cytokine Combinations With Philogen's Dr. Dario Neri
|
Jun 27, 2022 |
|
Fibroblasts In Regenerative Medicine with FibroBiologics' Pete O'Heeron & Dr. Hamid Khoja
|
Jun 20, 2022 |
|
Pyxis Oncology's Lara Sullivan, M.D. On Site-Specific ADCs And Change Management
|
Jun 13, 2022 |
|
The Biotech Beatdown With Allan Shaw
|
Jun 06, 2022 |
|
Inflammation & Antibodies with Ampio Pharmaceuticals' Mike Martino, CEO
|
May 30, 2022 |
|
What's Next For COVID Vaccines With Tonix Pharmaceuticals' Seth Lederman, M.D.
|
May 23, 2022 |
|
Running Interference: RNAi with Silence Therapeutics' Craig Tooman
|
May 16, 2022 |
|
Live Biologics & The Microbiome With 4D pharma's Duncan Peyton
|
May 09, 2022 |
|
Gene Tx For Renal Disease With Purespring CEO Richard Francis
|
May 02, 2022 |
|
Fighting Blindness & Funding The Fight With Opus Genetics' CEO Ben Yerxa, Ph.D.
|
Apr 25, 2022 |
|
Gynecological Cancer Therapies with Context Therapeutics' Martin Lehr
|
Apr 18, 2022 |
|
Commensal Viral Vectors with Ring Therapeutics' Tuyen Ong, M.D.
|
Apr 11, 2022 |
|
Antibodies For Severe Allergies With IgGenix's Jessica Grossman, M.D.
|
Apr 04, 2022 |
|
Gene Therapies For Ocular Disease With Sparing Vision's Stéphane Boissel
|
Mar 28, 2022 |
|
Biotech M&A Trends With Allan Shaw
|
Mar 21, 2022 |
|
Lipid Nanoparticle Gene Coding With SalioGen Therapeutics' Ray Tabibiazar, M.D.
|
Mar 14, 2022 |
|
CAR T-cells For Ovarian Cancer with Anixa Biosciences' Amit Kumar, Ph.D.
|
Mar 07, 2022 |
|
AI-Driven Biologics With Fountain Therapeutics' William Greene, M.D
|
Feb 28, 2022 |
|
Regulatory Harmonization With Aurion Biotech's Dr. Daniela Drago
|
Feb 21, 2022 |
|
Plant-Based Biologics With iBio's Randy Maddux
|
Feb 14, 2022 |
|
NK Cell Therapy Accessibility With Shoreline Biosciences' Dr. Kleanthis Xanthopoulos
|
Feb 07, 2022 |
|
A Hybrid mAb Manufacturing Model With John Glasspool
|
Jan 31, 2022 |
|
Biotech Capital Markets Forecast With Allan Shaw
|
Jan 24, 2022 |
|
Venture Philanthropy For Type 1 Diabetes With T1D Fund's Katie Ellias
|
Jan 17, 2022 |
|
Precision Approach To Infectious Disease With Locus Biosciences' Paul Garofolo
|
Jan 10, 2022 |
|
Bioengineering Human Tissue With Humacyte's Dr. Heather Prichard
|
Jan 03, 2022 |
|
The Top Stories Of 2021 With Allan Shaw
|
Dec 27, 2021 |
|
Complete CAR T Manufacturing Control with Cellectis' Steve Doares
|
Dec 20, 2021 |
|
Genomically-Guided Medicine with Elevation Oncology's Shawn Leland, PharmD, RPh
|
Dec 13, 2021 |
|
Inhalable mAbs & Vaccines with TFF's Glenn Mattes
|
Dec 06, 2021 |
|
Democratizing Biologics With Lumen Bioscience's Brian Finrow, J.D. & Craig Behnke, Ph.D.
|
Nov 29, 2021 |
|
Cornering The Antibody Market With Akesobio CEO Dr. Michelle Xia, Ph.D.
|
Nov 22, 2021 |
|
Turning The Liver Into A mAb Factory With Homology's Arthur Tzianabos, Ph.D.
|
Nov 15, 2021 |
|
Maximizing mRNA With Precision Nanosystems' James Taylor, Ph.D.
|
Nov 08, 2021 |
|
Foundations Of Flexible Manufacturing With Sarepta Therapeutics' Brian Winstead
|
Nov 01, 2021 |
|
The CDMO Capacity Crunch With Discovery Labs' Audrey Greenberg and Iovance Biotherapeutics' Sumit Verma
|
Oct 25, 2021 |
|
The Clinical Trials Conundrum with Allan Shaw
|
Oct 18, 2021 |
|
CMC Developability Assessments For Rapid Ph.1 Entry with AltruBio's Gene Lee, Ph.D.
|
Oct 11, 2021 |
|
CDMO With A Pipeline with Forge Biologics President & CEO Dr. Timothy J. Miller
|
Oct 04, 2021 |
|
Building A DNA Delivery System With Poseida Tx CEO Eric Ostertag, M.D., Ph.D.
|
Sep 27, 2021 |
|
From Bayer To Startup Bio With AltruBio's Dr. Judy Chou
|
Sep 20, 2021 |
|
Creating Competitive Differentiation With Allan Shaw
|
Sep 13, 2021 |
|
Gene Therapy Manufacturing Advances With Aruvant CTO Dr. Palani Palaniappan
|
Sep 06, 2021 |
|
iNK T-Cell Immuno-oncology For Solid Tumors With Dr. Ian Walters
|
Aug 30, 2021 |
|
How to Apply For BTD And Win It With Drs. Ira Gupta & Shanthi Ganeshan
|
Aug 23, 2021 |
|
Cold Chain Integrity & Sustainability With Celyad Oncology's Thomas Lequertier
|
Aug 16, 2021 |
|
Peptides & Proteins: Resetting The Immune System With Revolo CEO Jonathan Rigby
|
Aug 09, 2021 |
|
Intranasal Prophylactics For Flu & Coronavirus With Leyden Labs' Koenraad Weidhaup
|
Aug 02, 2021 |
|
Unpacking the SPAC With Allan Shaw
|
Jul 26, 2021 |
|
A Vaccine For Type 1 Diabetes With Diamyd Medical's Dr. Ulf Hannelius
|
Jul 19, 2021 |
|
CAR T Process Automation With Kite Pharma's Charles Calderaro III
|
Jul 12, 2021 |
|
Biopharma PR 101 with Matt Middleman, M.D.
|
Jul 05, 2021 |
|
A Scale-Up Story with Solis BioDyne Drs. Kadri Artma and Angela Vaasa
|
Jun 28, 2021 |
|
Academia + Industry with BridgeBio's Dr. Michael Henderson
|
Jun 21, 2021 |
|
GSK's Michael Mehler On The Cell & Gene Talent Crunch
|
Jun 14, 2021 |
|
RNA-Engineered Cell Therapy with Cartesian's Dr. Murat Kalayoglu
|
Jun 07, 2021 |
|
Real-Time Clinical Analysis with Glympse Bio's Dr. Caroline Loew
|
May 31, 2021 |
|
AAV & Lentivirus Gene Therapies with Sio Gene Therapeutics' Dr. Pavan Cheruvu
|
May 24, 2021 |
|
Med Device Meets Biopharma with OncoSec's Dan O'Connor, J.D.
|
May 17, 2021 |
|
Drug Development: From Bench To Bedside With Allan Shaw
|
May 10, 2021 |
|
Digital Transformation In Cell Therapy with Organicell Drs. Mari Mitrani & Michael Bellio
|
May 03, 2021 |
|
Biopharma Regulatory Requirements with bluebird bio's Scott Cleve
|
Apr 26, 2021 |
|
Filling A Vaccine Void with Cue Biopharma's Dan Passeri, J.D.
|
Apr 19, 2021 |
|
Supercharging An ADC Program With SOTIO CEO Dr. Radek Špíšek
|
Apr 12, 2021 |
|
mAb Manufacturing with Rezolute Bio CEO Nevan Charles Elam, JD
|
Apr 04, 2021 |
|
Cell Therapy Platforms With Precigen CEO Dr. Helen Sabzevari
|
Mar 28, 2021 |
|
A CFO's Prescription For Biopharma Success With Allan Shaw
|
Mar 21, 2021 |
|
A Biopharma Pivot with Compugen's Dr. Anat Cohen-Dayag
|
Mar 15, 2021 |
|
Preparing For The Clinic With Amolyt Pharma CEO Dr. Thierry Abribat
|
Mar 08, 2021 |
|
Pioneering Antiviral Conjugates with Cidara's Dr. Jeff Stein
|
Mar 01, 2021 |
|
AI & The Human Genome With Dr. Dietrich Stephan
|
Feb 22, 2021 |
|
The FDA's Progressive Appeal ft. Allan Shaw
|
Feb 15, 2021 |
|
Celyad CEO Filippo Petti On In-House Allogeneic Cell Therapy Manufacturing
|
Feb 08, 2021 |
|
Keeping Cell Therapy Clinicals On The Rails With Brian Culley
|
Feb 01, 2021 |
|
Orchard Tx's Bobby Gaspar On Manufacturing Hematopoietic Stem Cells
|
Jan 24, 2021 |
|
Acepodia's Approach To ACC & CAR Manufacturing Scalability
|
Jan 18, 2021 |
|
The AAV Vector Challenge With Selecta's Dr. Carsten Brunn
|
Jan 11, 2021 |
|
A Look Behind, A Look Ahead With Allan Shaw
|
Jan 04, 2021 |
|
Manipulating Milestones In Pandemic Times With AGTC's Sue Washer
|
Dec 21, 2020 |
|
Gene Therapy Manufacturing At-Scale With Geoff MacKay
|
Dec 07, 2020 |
|
Bacterial Therapy: Modulation of the Microbiome With Dr. Bernat Olle
|
Nov 23, 2020 |
|
Foundations Of Biopharma Finance With Smital Shah
|
Nov 09, 2020 |
|
Off-The-Shelf CAR T-Cell Therapy with John McKearn, Ph.D.
|
Oct 26, 2020 |
|
CAR T Therapy Cost Control With Laurence Cooper, M.D., Ph.D.
|
Oct 13, 2020 |
|
010: Gap Analysis With Dr. Pablo Valenzuela & Cristián Hernández-Cuevas
|
Sep 28, 2020 |
|
009: CMC Considerations For In-Human Studies with Drs. Edith Perez & Nathan Ihle
|
Sep 21, 2020 |
|
008: Commitment To GMP With Dr. Shabbir Anik
|
Sep 14, 2020 |
|
007: Quality Data For FDA Submissions With Dr. Robert Hariri
|
Sep 08, 2020 |
|
Summer Sessions 8: Dr. Gaurav Shah, Rocket's Chief Gene Therapist & Virtuoso
|
Aug 31, 2020 |
|
Summer Sessions 7: Dr. Randall Schatzman & The New Fundraising Norm
|
Aug 24, 2020 |
|
Summer Sessions 6: Alexis Peyroles On Myeloid Cells, Transplants, & Immuno-Oncology Inspiration
|
Aug 17, 2020 |
|
Summer Sessions 5: Dr. Christopher Anzalone Takes RNAi Beyond The Liver
|
Aug 10, 2020 |
|
Summer Sessions 4: Dr. Loretta Itri On Taking ADCs Across The Finish Line
|
Aug 03, 2020 |
|
Summer Sessions 3: Jeff Wolf Builds Heat Bio On Its Therapeutic Platform
|
Jul 27, 2020 |
|
Summer Sessions 2: Dr. Paul Wotton Solves A COVID-19 Workforce Crisis
|
Jul 20, 2020 |
|
Summer Sessions 1: Ivor Macleod brings big-league finance experience to an emerging biotech
|
Jul 13, 2020 |
|
006: Leaving The Incubator With Kavitha Iyer Rodrigues
|
Jun 29, 2020 |
|
005: Building A Biotech All-Star Team With Vivek Ramaswamy
|
Jun 15, 2020 |
|
004: Finding Funding In Volatile Times With Dr. Ben Zeskind
|
Jun 01, 2020 |
|
003: Building The Biopharma Pitch With Leslie Williams
|
May 18, 2020 |
|
002: The Biopharma Exit Strategy With Dr. Francois Nader
|
May 04, 2020 |
|
001: The Business Of Biotech: Allan Shaw
|
Apr 20, 2020 |
|
Business Of Biotech Trailer
|
Apr 14, 2020 |